Henry Schein (NASDAQ:HSIC) Earns “Outperform” Rating from Barrington Research

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating reaffirmed by analysts at Barrington Research in a note issued to investors on Wednesday, Benzinga reports. They currently have a $82.00 price target on the stock. Barrington Research’s price target would suggest a potential upside of 16.86% from the stock’s previous close.

Several other brokerages also recently commented on HSIC. StockNews.com downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Robert W. Baird reduced their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus price target of $77.50.

Henry Schein Trading Up 1.7 %

Henry Schein stock traded up $1.18 during mid-day trading on Wednesday, hitting $70.17. 806,130 shares of the stock were exchanged, compared to its average volume of 1,345,992. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein has a 12 month low of $62.05 and a 12 month high of $82.63. The firm’s fifty day simple moving average is $70.60 and its two-hundred day simple moving average is $69.78. The stock has a market capitalization of $8.89 billion, a price-to-earnings ratio of 25.86, a PEG ratio of 2.02 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.06. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter last year, the business earned $1.32 EPS. The company’s revenue was up .4% compared to the same quarter last year. Analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in HSIC. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Henry Schein by 11.8% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company’s stock worth $2,186,000 after purchasing an additional 2,954 shares during the period. Nordea Investment Management AB grew its position in Henry Schein by 8.9% in the first quarter. Nordea Investment Management AB now owns 9,785 shares of the company’s stock worth $744,000 after acquiring an additional 798 shares in the last quarter. Daiwa Securities Group Inc. grew its position in Henry Schein by 11.0% in the first quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company’s stock worth $972,000 after acquiring an additional 1,279 shares in the last quarter. Empirical Finance LLC grew its position in Henry Schein by 3.5% in the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after acquiring an additional 160 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in Henry Schein by 64.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after acquiring an additional 16,241 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.